Medication info
Monorova Tablet 20 Milligrams (Rosuvastatin Calcium)

Monorova Tablet 20 Milligrams (Rosuvastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tablet
Manufacturer / importer
Yuhan Corporation
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201400111 · Approved 2014.01.10 · Insurance code 642104420

Summary

Main use
Improves dyslipidemia, inhibits the progression of atherosclerosis, and prevents cardiovascular disease
Who takes it
Adults · Children
Adult dose
1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted as a maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more, according to LDL cholesterol levels, the treatment goal, and the patient's response; the dose may be increased to a maximum of 20 mg daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. This medicine should not be administered to patients with severe renal impairment. Particular caution should be exercised when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or below, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with use in patients with a Child-Pugh score above 9. This medicine should not be administered to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. A dose of 40 mg is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. A dose of 40 mg of this medicine is contraindicated in some of these patients.
Child dose
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Maximum daily dose: 20 milligrams. Under 10 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
Yuhan Corporation

Efficacy & effects

Improves dyslipidemia, inhibits the progression of atherosclerosis, and prevents cardiovascular disease

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • dysbetalipoproteinemia
  • cardiovascular disease risk factors
  • stroke risk
  • myocardial infarction risk
  • arterial revascularization risk
View approved original text

This medication is used as an adjunct when dietary measures and exercise are insufficient for controlling primary hypercholesterolemia and mixed dyslipidemia. It is particularly beneficial for patients with heterozygous familial hypercholesterolemia or dysbetalipoproteinemia. It lowers total cholesterol and LDL-cholesterol levels, delaying the progression of atherosclerosis and reducing the risk of cardiovascular disease. Additionally, it is suitable for some pediatric patients aged 10 to 17 years and serves as a safe dietary supplement. It reduces the risk of stroke, myocardial infarction, and arterial revascularization in middle-aged and elderly patients with high hypersensitive C-reactive protein levels and additional cardiovascular risk factors. Overall, this medication is used to improve the risk of various cardiovascular diseases associated with dyslipidemia.

How to take

Adult dose

1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted as a maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more, according to LDL cholesterol levels, the treatment goal, and the patient's response; the dose may be increased to a maximum of 20 mg daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. This medicine should not be administered to patients with severe renal impairment. Particular caution should be exercised when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or below, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with use in patients with a Child-Pugh score above 9. This medicine should not be administered to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. A dose of 40 mg is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. A dose of 40 mg of this medicine is contraindicated in some of these patients.

Child dose

Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Maximum daily dose: 20 milligrams. Under 10 years of age: Safety and efficacy have not been established.

Precautions

This medication should not be used in certain patients. First, it should not be administered to patients with a known allergy to this medication, those with severely impaired liver function, patients with muscle disorders, and those with significantly reduced kidney function. Additionally, it should not be used by pregnant or nursing women, or women of childbearing age who are not using effective contraception. The 40 milligrams dosage is contraindicated for patients at high risk for muscle disorders. Caution should be exercised in patients who consume large amounts of alcohol or have a history of liver disease. Liver function tests should be repeated before and during administration, and any thyroid dysfunction or nephrotic syndrome should be treated prior. If symptoms such as myalgia, muscle weakness, or cramps occur during treatment, immediate medical attention should be sought. In particular, if there is a significant increase in muscle enzyme levels, the medication should be discontinued, and it can be restarted at a lower dose once symptoms improve. This medication may interact with certain drugs, so it is essential to consult a healthcare provider about any medications being taken concurrently. Particularly, concomitant use with certain antiviral agents, immunosuppressants, some antibiotics, and fibrate class drugs may increase the risk of muscle-related side effects. This medication should be avoided during pregnancy due to potential risks to the fetus, and it is also advisable to avoid use during lactation. In cases of overdose, there are no specific antidotes, so treatment should be symptomatic, and liver and muscle function tests are required. Patients may experience dizziness while on this medication; therefore, caution is advised when driving or operating machinery. Finally, this medication can rarely cause severe skin reactions, liver dysfunction, or muscle damage, so any abnormal symptoms should be reported to healthcare professionals immediately.

Side effects

Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, shortness of breath, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius. This will help preserve the medication's effectiveness for an extended period.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.